Bcl−2 protects from lethal hepatic apoptosis induced by an ant−Fas antibody in mice

1. Thompson, C.B. Apoptosis in the pathogenesis and treatment of disease. Science 267, 1456−1462 (1995).
2. Nagata, S. & Golstein, P., Fas death factor. Science 267, 1449−1456 (1995).
3. Suda, T. & Nagata, S. Purification and characterization of the Fas-ligand that induces apoptosis. J. Exp. Med. 179, 873−879 (1994).
4. Itoh, N. et al. The polypeptide encoded by the cDNA for the human cell surface antigen Fas can mediate apoptosis. Cell 66, 233−243 (1991).
5. Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301−304 (1989).
6. Rouvier, E., Luciani, M.F. & Golstein, P. Fas involvement in Ca²⁺-independent T cell-mediated cytotoxicity. J. Exp. Med. 177, 195−200 (1993).
7. Kagi, D. et al. Fas and perform pathways as major mechanisms of T cell-mediated cytotoxiclty. Science 265, 528−530 (1994).
8. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. Lymphoproliferative disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314−317 (1992).
9. Takahashi, T. et al. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76, 969−976 (1994).
10. Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347−1349 (1995).
11. Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935−946 (1995).
12. Zornig, M., Grzeschiczek, A., Kowalski, M.B., Hartmann, K.U. & Moroy, T. Loss of Fas/APO-1 receptor accelerates lymphomagenesis in Em L-Myc transgenic mice but not in animals infected with MoMuLV. Oncogene 10, 2397−2401 (1995).
13. Weller, M., Malipiero, U., Aguzzi, A., Reed, J.C. & Fontana, A., Protooncogene bcl-2 gene transfer abrogates Fas/APO-1 antibody-mediated apoptosis of human malignant glioma cells and confers resistance to chemotherapeutic drags and therapeutic irradiation. J. Clin. Invest. 95, 2633−2643 (1995).
14. Watanabe, D., Suda, T., Hashimoto, H. & Nagata, S. Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J. 14, 12−18 (1995).
15. Hiramatsu, N. et al. Immunohistochemical detection of Fas antigen in liver tissue of patients with chronic hepatitis C. Hepatology 19, 1354−1359 (1994).
16. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806−809 (1993).
17. Cleveland, J.L. & Ihle, J.N. Contenders in FasL/TNF death signalling. Cell 81, 479−482 (1995).
18. Enari, M., Hug, H. & Nagata, S. Involvement of an ICE-like protease in Fas-mediated apoptosis. Nature 375, 78−81 (1995).
19. Los, M. et al. Requirement of an ICE/CED-3 protease for Fas/APO-1-mediated apoptosis. Nature 375, 81−83 (1995).
20. Korsmeyer, S.J. Regulators of cell death. Trends Genet. 11, 101−104 (1995).
21. Itoh, N., Tsujimoto, Y. & Nagata, S. Effect of Bcl-2 on Fas antigen-mediated cell death. J. Immunol. 151, 621−627 (1993).
22. Chiu, V.K., Walsh, C.M., Liu, C.C., Reed, J.C.& Clark, W.R. Bcl-2 blocks degranulation but not Fas-based cell-mediated cytotoxicity. J. Immunol. 154, 2023−2032 (1995).
23. Vaux, D.L., Aguila, H.L. & Weissman, I.L. Bcl-2 prevents death of factor deprived cells but fails to prevent apoptosis in targets of cell-mediated killing. Int. Immunol. 4, 821−826 (1992).
24. Tsujimoto, Y. & Croce, C.M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc. Natl. Acad. Sci. USA 83, 5214−5218 (1986).
25. Miquerol, L. et al. Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J. Biol. Chem. 269, 8944−8951 (1994).
26. Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274−1279 (1992).
27. Tsujimoto, Y., Cossman, J., Jaffe, E. & Croce, C.M. Involvement of the bcl-2 gene in human follicular lymphoma. Science 228, 1440−1443 (1985).
28. Reed, J.C. Bcl-2 and the regulation of programmed cell death. J. Cell. Biol. 124, 1−6 (1994).
29. Zhao, M., Zhang, N.X., Economou, M., Laissue, J.A. & Zimmerman, A. Immunohistochemical detection of Bcl-2 protein in liver lesions: Bcl-2 protein is expressed in hepatocellular carcinomas but not in liver cell dysplasia. Histopathology 25, 237−245 (1994).
30. Krajewski, S. et al. Immunohistochemical determination of in vivodistribution of Bax, a dominant inhibitor of Bcl-2. Am. J. Pathol. 145, 1323−1336 (1994).
31. Kiefer, M.C. et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 374, 736−739 (1995).
32. Oltvai, Z.N. & Korsmeyer, S.J. Checkpoints of dueling dimers foil death wishes. Cell 79, 189−192 (1994).
33. Oltvai, Z.N., Milliman, C.L. & Korsmeyer, S.J. Bcl-2 heterodimerizes in vivowith a conserved homolog, Bax, that accelerates programmed cell death. Cell 74, 609−619 (1993).
34. Yang, E. et al. Bad, a heterodimeric partner for Bcl-X_L and Bcl-2, displaces Bax and promotes cell death. Cell 80, 285−291 (1995).
35. Boise, L.H. et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74, 597−608 (1993).
36. Mita, E. et al. Role of Fas ligand in apoptosis induced by hepatitis C virus infection. Biochem. Biophys. Res. Commun. 204, 468−474 (1994).
37. Rehermann, B. et al. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181, 1047−1058 (1995).
38. Ando, K. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. Exp. Med. 178, 1541−1554 (1993).
39. Takahashi, H., Fujimoto, J., Hanada, S. & K J.Acute hepatitis in rats expressing human hepatitis B virus transgenes. Proc. Natl. Acad. Sci. USA 92, 1470−1474 (1995).
40. Lacronique, V. et al. Identification and functional characterization of an erythroid-specific enhancer in the L-type pyruvate kinase gene. J. Biol. Chem. 270, 14989−14997 (1995).
41. Chirgwin, J.M., Przybyla, A.E., MacDonald, R.J. & WJ.Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18, 5294−5299 (1979).
42. Giannini, G. et al. The ryanodine receptor/calcium channel genes are widely and differentially expressed in murine brain and peripheral tissues. J. Cell Biol. 128, 893−904 (1995).

	Top

	Top